Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neos Therapeutics, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neos Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Neos Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is NEOS. The reporting company's CIK number is 1467652.
The total value of stock buying since 2005 is $7,139,012.
The total value of stock sales since 2005 is $3,297,015.
The total value of stock option exercises since 2005 is $40,291.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-11-08||Heller Alan L (Director)||Buy||43,478||2.30||99,999|
|2016-08-25||Eisenstadt Richard I (Chief Financial Officer)||Buy||3,710||6.82||25,283|
|2016-06-13||Martens Juergen (Chief Tech/Operations Officer)||Buy||10,000||9.90||99,000|
|2016-05-19||Mcdonnell Thomas P (Chief Commercial Officer)||Buy||3,000||7.56||22,671|
|2016-05-19||Heller Alan L||Buy||10,000||7.61||76,100|
|2016-05-18||Robitaille Gregory J||Buy||7,442||7.54||56,149|
|2016-04-20||Sohail Faysal A. (10% Owner)||Sale||8,540||9.88||84,409|
|2016-04-19||Sohail Faysal A. (10% Owner)||Sale||7,279||10.03||73,001|
|2016-04-18||Sohail Faysal A. (10% Owner)||Sale||4,548||10.10||45,934|
|2016-04-15||Sohail Faysal A. (10% Owner)||Sale||18,210||10.22||186,142|
|2016-04-14||Sohail Faysal A. (10% Owner)||Sale||27,066||10.29||278,563|
|2016-04-13||Sohail Faysal A. (10% Owner)||Sale||12,692||10.16||128,976|
|2015-09-28||Robitaille Gregory J||Option Ex||410||.32||131|
|2015-07-28||Essex Capital Corp (10% Owner)||Buy||30,000||15.00||450,000|
|2015-07-28||Deerfield Private Design Fund Iii, L.p.||Buy||400,000||15.00||6,000,000|
|2015-07-28||Deerfield Private Design Fund Iii, L.p.||Sale||166,666||15.00||2,499,990|
|2015-07-28||Schuler Jack W (10% Owner)||Buy||20,000||15.00||300,000|
|2015-07-27||Heller Alan L (Director)||Option Ex||30,540||1.31||40,160|
Insider trading activities including stock purchases, stock sales, and option exercises of NEOS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neos Therapeutics, Inc. (symbol NEOS, CIK number 1467652) see the Securities and Exchange Commission (SEC) website.